Seeking Alpha

Geron (GERN) soars 11% as option activity takes off on the biopharmaceutical company with calls...

Geron (GERN) soars 11% as option activity takes off on the biopharmaceutical company with calls outpacing puts by 50-to-1. Traders may be looking favorably at new data suggesting stem cells can be used to treat patients disabled by stroke.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector